Myelodysplasia and Myeloproliferative Disorder Care

Blood disease doesn’t discriminate, but access to great hematology care hasn’t always been the same for everyone. At Providence, we are deeply committed to making sure every patient we treat has access to the best care. We offer various location-specific services to help our patients receive equitable care, such as translation for non-English-speaking patients, telehealth and transportation assistance. We value, respect and support the racial, ethnic, religious, spiritual, gender, and sexual identities of each member of our diverse communities, and we welcome all patients, regardless of their ability to pay. We aim to make sure every patient is treated equally and with dignity – whoever you are, and wherever you’re at. 

As a patient at Providence, you have access to the largest community-based network in the United States. Being part of a collaborative network means that your local myelodysplasia and myeloproliferative disorder care team shares knowledge and experience with other world-class clinicians across 52 hospitals in seven states. The extent and power of our network is one of the reasons so many patients choose Providence for their hematology care each year.

Providence is well-known for offering options – and hope – to patients seeking the most advanced procedures and therapies to treat myelodysplasia and myeloproliferative disorders. Our network of experts and state-of-the-art labs offer the most advanced medical insights and treatments for our patients, such as molecular analysis of bone marrow and coagulation diagnostics. We look at the stage and the genetic makeup of your specific condition to determine which clinical trial could be most effective for you.